| The Drug-drug Interaction of SHR3824 and SP2086 (NCT02500485) | Jiangsu HengRui Medicine Co., Ltd. | 2015-05-01 |
| A Study of Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+Metastatic Breast Cancer Who Have Prior Received Anthracyclin, Taxane or Trastuzumab (NCT02422199) | Jiangsu HengRui Medicine Co., Ltd. | 2015-05-01 |
| First-in-Human Single Ascending Dose of SHR0302 (NCT02423538) | Jiangsu HengRui Medicine Co., Ltd. | 2015-04-01 |
| A Phase I Study of Fluzoparib in Patient With Advanced Solid Malignancies (NCT02575651) | Jiangsu HengRui Medicine Co., Ltd. | 2015-04-01 |
| Efficacy and Safety of Pregabalin Sustained Release Tablet for Postherpetic Neuralgia (NCT02868801) | Jiangsu HengRui Medicine Co., Ltd. | 2015-03-01 |
| A Phase 1, Randomized, Placebo-controlled, Multiple Dose Escalation Study to Investigate Safety, Pharmacokinetics, and Pharmacodynamics of SHR0534 in Chinese Type 2 Diabetic Patients (NCT03006159) | Jiangsu HengRui Medicine Co., Ltd. | 2015-03-01 |
| The PK/PD, Efficacy, Safety and Tolerability Study of SHR3824 in Type 2 Diabetes Mellitus Patients (NCT02366351) | Jiangsu HengRui Medicine Co., Ltd. | 2015-02-01 |
| The PK/PD, Efficacy, Safety and Tolerability Study of SHR3824 in Combination With Metformin in Type 2 Diabetes Mellitus Patients (NCT02366377) | Jiangsu HengRui Medicine Co., Ltd. | 2015-02-01 |
| A Phase 1, Randomized, Placebo-controlled, Single & Multiple Dose Escalation Study to Investigate Safety, Pharmacokinetics, and Pharmacodynamics of SHR0534 in Healthy Chinese Volunteers (NCT02750553) | Jiangsu HengRui Medicine Co., Ltd. | 2015-01-01 |
| Efficacy and Safety of Azilsartan Compared to Olmesartan Medoxomil in Chinese Participants With Grade I or II Essential Hypertension (NCT02407210) | Jiangsu HengRui Medicine Co., Ltd. | 2015-01-01 |
| Pharmacokinetics of Imrecoxib in Subjects With Hepatic Insufficiency (NCT02456688) | Jiangsu HengRui Medicine Co., Ltd. | 2015-01-01 |
| A Drug Drug Interaciton Study of Imrecoxib and Warfarin in Healthy Volunteers (NCT02426060) | Jiangsu HengRui Medicine Co., Ltd. | 2015-01-01 |
| A Study of Famitinib Plus Docetaxel in Patients With Advanced Non-squamous and Non-Small Cell Lung Cancer (NSCLC) (NCT02364362) | Jiangsu HengRui Medicine Co., Ltd. | 2015-01-01 |
| Study of Apatinib as 3rd/4th Line Treatment in Patients With Advanced Non-Squamous Non-small Cell Lung Cancer Harboring Wild-type Epidermal Growth Factor Receptor (EGFR) (NCT02332512) | Jiangsu HengRui Medicine Co., Ltd. | 2015-01-01 |
| Safety and Efficacy Study of Famitinib in Patients With Advanced Colorectal Adenocarcinoma（FACT） (NCT02390947) | Jiangsu HengRui Medicine Co., Ltd. | 2015-01-01 |
| A Study of Famitinib in Patients With Advanced Non-squamous and Non-Small Cell Lung Cancer (NSCLC) (NCT02356991) | Jiangsu HengRui Medicine Co., Ltd. | 2014-12-01 |
| A Study Comparing Remimazolam Tosilate and Propofol for Intravenous General Anaesthesia in Operations (NCT02406872) | Jiangsu HengRui Medicine Co., Ltd. | 2014-12-01 |
| A Study of Irinotecan Hydrochloride Liposome in Advanced Solid Tumors (NCT05086822) | Jiangsu HengRui Medicine Co., Ltd. | 2014-09-09 |
| The Drug-drug Interaction of SHR3824 and Metformin (NCT02354027) | Jiangsu HengRui Medicine Co., Ltd. | 2014-09-01 |
| Study Evaluating Pyrotinib/Pyrotinib in Combination With Docetaxel in Patients With HER2+ Advanced Gastric Cancer (NCT02378389) | Jiangsu HengRui Medicine Co., Ltd. | 2014-09-01 |
| Study Evaluating Pyrotinib in Combination With Capecitabine In Patients With HER2 Positive Metastatic Breast Cancer (NCT02361112) | Jiangsu HengRui Medicine Co., Ltd. | 2014-08-01 |
| A Phase Ⅰb Study of Remimazolam Tosylate in Healthy Volunteers (NCT03444480) | Jiangsu HengRui Medicine Co., Ltd. | 2014-07-23 |
| SP2086 Pharmacokinetic Study in Renal Insufficiency Patients (NCT02815774) | Jiangsu HengRui Medicine Co., Ltd. | 2014-06-01 |
| Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of SHR3824 in Type 2 Diabetes Mellitus Patients (NCT02346175) | Jiangsu HengRui Medicine Co., Ltd. | 2014-06-01 |
| Effect of a High-fat Meal on the Pharmacokinetics of SHR3824 and Mass Balance Study in Healthy Subjects (NCT02353975) | Jiangsu HengRui Medicine Co., Ltd. | 2014-05-01 |
| Clinical Trial of Systolic Heart Failure Treatment of IvabRadine Hemisulfate Sustained-release Tablets （FIRST） (NCT02188082) | Jiangsu HengRui Medicine Co., Ltd. | 2014-05-01 |
| A Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients (NCT02403440) | Jiangsu HengRui Medicine Co., Ltd. | 2014-04-01 |
| Study of Apatinib After Systemic Therapy in Patients With Hepatocellular Carcinoma(AHELP) (NCT02329860) | Jiangsu HengRui Medicine Co., Ltd. | 2014-03-26 |
| Effect of a High-fat Meal on the Pharmacokinetics of Hetrombopag and Mass Balance Study in Healthy Subjects (NCT02409394) | Jiangsu HengRui Medicine Co., Ltd. | 2014-03-01 |
| The Drug -Drug Interaction of SP2086 and Glyburide (NCT02815787) | Jiangsu HengRui Medicine Co., Ltd. | 2014-03-01 |
| A Phase Ⅲ Study of Extended-Release Carvedilol Sulfate for the Treatment of Heart Failure (NCT02012075) | Jiangsu HengRui Medicine Co., Ltd. | 2013-12-01 |
| The PK/PD Study of Multiple Dose of SHR3824 in Healthy Volunteers (NCT02361138) | Jiangsu HengRui Medicine Co., Ltd. | 2013-12-01 |
| A Phase Ⅰa Study of Remimazolam Tosylate in Healthy Volunteers (NCT01970072) | Jiangsu HengRui Medicine Co., Ltd. | 2013-10-14 |
| A PHASE I, RANDOMIZED, PLACEBO-CONTROLLED, SINGLE DOSE ESCALATION STUDY TO INVESTIGATE SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS OF SHR0534 IN HEALTHY VOLUNTEERS (NCT02749097) | Jiangsu HengRui Medicine Co., Ltd. | 2013-10-01 |
| A Phase Ⅲ Study of Extended-Release Carvedilol Sulfate for the Treatment of Hypertension (NCT01970059) | Jiangsu HengRui Medicine Co., Ltd. | 2013-10-01 |
| The Drug-drug Interaction of SP2086 and Simvastatin (NCT02815722) | Jiangsu HengRui Medicine Co., Ltd. | 2013-07-01 |
| The PK/PD Study of Single Dose of SHR3824 in Healthy Volunteers (NCT02356224) | Jiangsu HengRui Medicine Co., Ltd. | 2013-06-01 |
| A Phase 4 Study of Imrecoxib in Treatment of Knee Osteoarthritis (NCT01985165) | Jiangsu HengRui Medicine Co., Ltd. | 2013-05-01 |
| A Phase III Study of SP2086 in Combination With Metformin in Patients With Type 2 Diabetes (NCT01970046) | Jiangsu HengRui Medicine Co., Ltd. | 2013-04-01 |
| The Drug-drug Interaction of SP2086 and Valsartan (NCT02815657) | Jiangsu HengRui Medicine Co., Ltd. | 2013-04-01 |
| Study of Pyrotinib in Patients With Human Epidermalgrowth Factor Receptor 2 (HER2) Positive Advanced Breast Cancer (NCT01937689) | Jiangsu HengRui Medicine Co., Ltd. | 2013-01-01 |
| Efficacy and Safety of SP2086 as Monotherapy in Patients With Type 2 Diabetes (NCT01970033) | Jiangsu HengRui Medicine Co., Ltd. | 2012-12-01 |
| Efficacy and Safety Study of SHR117887 in Combination With Metformin in Patients With Type 2 Diabetes (NCT01984489) | Jiangsu HengRui Medicine Co., Ltd. | 2012-06-01 |
| A PK/PD Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes (NCT01965509) | Jiangsu HengRui Medicine Co., Ltd. | 2012-05-01 |
| A Study of Famitinib in Patients With Advanced Colorectal Cancer (NCT01762293) | Jiangsu HengRui Medicine Co., Ltd. | 2012-04-01 |
| A Phase I Study of Hetrombopag Olamine in Healthy Adult Volunteers (NCT01830660) | Jiangsu HengRui Medicine Co., Ltd. | 2012-04-01 |
| A Study of Pegylated rhG-CSF as Support to Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Receiving Chemotherapy (NCT01560195) | Jiangsu HengRui Medicine Co., Ltd. | 2012-04-01 |
| A Study of Famitinib in Patients With Gastrointestinal Stromal Tumor (NCT02336724) | Jiangsu HengRui Medicine Co., Ltd. | 2012-03-01 |
| Efficacy and Safety Study of SP2086 in Combination With Metformin in Patients With Type 2 Diabetes (NCT01969318) | Jiangsu HengRui Medicine Co., Ltd. | 2012-03-01 |
| A Phase I Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes (NCT01965496) | Jiangsu HengRui Medicine Co., Ltd. | 2012-03-01 |
| A Study Comparing Pegylated rhG-CSF and rhG-CSF as Support to Breast Cancer Patients Receiving Chemotherapy (NCT01611051) | Jiangsu HengRui Medicine Co., Ltd. | 2012-03-01 |
| Efficacy and Safety Study of the Tolvaptan Tablets in Patients With Non-hypovolemic Non-acute Hyponatremia (NCT01507727) | Jiangsu HengRui Medicine Co., Ltd. | 2012-01-01 |
| Concurrent Chemoradiotherapy With Famitinib for Patients With Locally Advanced Nasopharyngeal Carcinoma (NCT01462474) | Jiangsu HengRui Medicine Co., Ltd. | 2011-10-01 |
| A Study of Famitinib in Patients With Advanced or Metastatic Gastroenteropancreatic Neuroendocrine Tumor (NCT01994213) | Jiangsu HengRui Medicine Co., Ltd. | 2011-10-01 |
| A Phase II Study of Flumatinib Versus Imatinib to Treat Philadelphia Chromosome Positive Chronic Myelogenous Leukemia (NCT01503502) | Jiangsu HengRui Medicine Co., Ltd. | 2011-08-01 |
| Famitinib in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma (NPC) (NCT01392235) | Jiangsu HengRui Medicine Co., Ltd. | 2011-07-01 |
| A Study of the Effectiveness and Safety of SP2086 to Treat Type 2 Diabetes (NCT01969357) | Jiangsu HengRui Medicine Co., Ltd. | 2011-06-01 |
| A Phase I Study of 8-week Continuous Treatment With Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes (NCT01976858) | Jiangsu HengRui Medicine Co., Ltd. | 2011-06-01 |
| A Study of Famitinib in Patients With Advanced Metastatic Renal Cell Cancer (NCT01829841) | Jiangsu HengRui Medicine Co., Ltd. | 2011-05-01 |
| Dose Finding and Pharmacokinetics/Pharmacodynamics Study of Apatinib in the Treatment of Advanced Colorectal Cancer (NCT01531777) | Jiangsu HengRui Medicine Co., Ltd. | 2011-04-01 |
| A Phase II Study Comparing Pegylated rhG-CSF（HHPG-19K） and rhG-CSF in Breast Cancer Patients Receiving Chemotherapy (NCT02119715) | Jiangsu HengRui Medicine Co., Ltd. | 2011-02-01 |
| Study of Cipatinib in Patients With HER2 Positive or Uncertain Advanced Breast Cancer (NCT01301911) | Jiangsu HengRui Medicine Co., Ltd. | 2011-01-01 |
| Phase III Study of Apatinib Tablets in the Treatment of Advanced or Metastatic Gastric Cancer (NCT01512745) | Jiangsu HengRui Medicine Co., Ltd. | 2011-01-01 |
| A Phase I Study of Henatinib in Patients With Advanced Solid Malignancies (NCT01416623) | Jiangsu HengRui Medicine Co., Ltd. | 2010-09-01 |
| A Study of Apatinib in Patients With Advanced Hepatocellular Carcinoma (NCT01192971) | Jiangsu HengRui Medicine Co., Ltd. | 2010-06-01 |
| A Study of Apatinib in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer (NCT01270386) | Jiangsu HengRui Medicine Co., Ltd. | 2010-03-01 |
| A Phase I Study of Famitinib Malate in Patients With Solid Tumor (NCT01762280) | Jiangsu HengRui Medicine Co., Ltd. | 2009-06-01 |